Los pacientes con enfermedad inflamatoria intersticial no constituyen una población de riesgo para adquirir la infección por SARS-CoV-2

by CIBEREHD-Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

3 years ago
inmunosupresores, enfermedad inflamatoria intestinal, infección, covid-19, inmunosupresores

Javier P. Gisbert y María Chaparro, investigadores del CIBEREHD pertenecientes al Hospital de La Princesa han participado en un estudio internacional multicéntrico para aclarar los riesgos de los pa...

Optimizing our 'new normal' to achieve exceptional innovation in 2021 and beyond

by CAS, a division of the American Chemical Society

3 years ago
sustainability, covid-19, innovation, work environments, research, data, CAS

The past year was unquestionably challenging for many of us. As I reflect on 2020, however, it is not only the challenges that will stick with me, but also the surprising amount that was achieved. The...

La UJI consolida el ámbito biomédico y de salud pública con la incorporación de dos investigadoras de programas de excelencia

by Universitat Jaume I

3 years ago
COVID-19, contagios, UJI, salud, biomédico, infección

La Universitat Jaume I de Castelló ha reforzado durante 2020 la investigación en el ámbito biomédico y de salud pública con la incorporación de dos investigadoras en programas de excelencia Beat...

Pall Corporation Invests $114M to Expand Global Production Capacity

by Pall Biotech

3 years ago
covid-19, Invests, Pall, production capacity, manufacturing solutions, vaccines, genes therapies

Pall Corporation expands production capacity in the United States and Europe to support industry demand

La Comisión Europea autoriza el uso de la vacuna de Moderna

by Agencia Sinc

3 years ago
covid-19, Moderna, vacuna, EMA, ARN mensajero

Tras el visto bueno de su Agencia de Medicamentos, la Unión Europea ha aprobado la comercialización de la vacuna de Moderna, que proporcionará 160 millones de dosis hasta el tercer trimestre de 202...

Comunicado sobre la nueva cepa de SARS-CoV-2, la variante VUI-202012/01

by IrsiCaixa

3 years ago
COVID-19, Seguimiento Científico, SARS-CoV-2, vacuna, cepa

El investigador principal de IrsiCaixa y componente del Grupo Colaborativo Multidisciplinar para el Seguimiento Científico de la COVID-19 (GCMSC), Julià Blanco, ha coordinado la elaboración de un c...

Histocell successfully completes the clinical safety phase of its cell therapy drug HC016 for the treatment of acute respiratory distress caused by COVID-19

by Histocell Regenerative Medicine

3 years ago
cell therapy drug, respiratory distress, COVID-19

This is the Phase I clinical trial of the cell therapy drug HC016 developed by Histocell, which is being carried out at the Hospital de Cruces (Bilbao), in Spain. The objective of this trial is to off...

Covid-19 drives innovation and makes healthcare investment spike

by Biocat

3 years ago
covid-19, investment, healthcare, ONA Therapeutics, Sabadell Asabys, Ability Pharma, Minoryx, Atrys Health, Oryzon Genomics

Covid-19 pandemic has boosted cutting-edge research and innovation, reaching a record investment for companies in the BioRegion

Estudian los efectos beneficiosos de la proteína gelsolina para evitar las complicaciones pulmonares derivadas de la covid-19

by Universitat Rovira i Virgili

3 years ago
covid-19, proteína gelsolina, pulmonar

Investigadores de la URV, Hospital Universitario Sant Joan de Reus i el IISPV, lideran un ensayo clínico Fase II, en colaboración con la empresa biotecnológica de Nueva Jersey BioAegis Therapeutics...

Impacto del confinamiento y la pandemia COVID-19 en personas con o sin un trastorno mental

by Fundació Clínic per a la Recerca Biomèdica

3 years ago
trastorno mental, pandemia, confinamiento, covid-19

Investigadores del Clínic-IDIBAPS y del CIBERSAM han publicado un artículo en la revista Journal of Affective Disorders que concluye que las personas con un trastorno mental suelen presentar mayores...

Brain Health for Life raises awareness of most cutting-edge research in brain conditions

by Biocat

3 years ago
Brain Health, investigation, brain diseases, Innovation Track, covid-19

One in four people in the world have a psychiatric or neurological condition. The course Brain Health for Life. Preventing Brain-Related Disability, promoted by EIT Health and organized by Biocat, the...

Oh, what a year it’s been! Lessons learned amid the pandemic

by CAS, a division of the American Chemical Society

3 years ago
scientists, lessons, pandemic, covid-19, vaccines

We began 2020 refreshed and hopeful, with plans to publish unique perspectives and insights to inspire new ideas in the months to come—but COVID-19 changed everything. As the world adapted and recon...